Literature DB >> 12594853

Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18.

Naotoshi Sugimoto1, Masakiyo Nakahira, Hyun-Jong Ahn, Mark Micallef, Toshiyuki Hamaoka, Masashi Kurimoto, Hiromi Fujiwara.   

Abstract

IL-12 activates TYK2 and Janus kinase (JAK)-2 to induce the phosphorylation of various signal transducers and activators of transcription (STAT) proteins. However, little is known regarding how these JAK exhibit the distinct biological effects of IL-12. Using two JAK inhibitors, tyrphostin A1 (A1) for TYK2 and tyrphostin B42 (B42) for JAK2, we investigated the involvement of JAK2 and TYK2 in IL-12-induced T cell proliferation and IFN-gamma production. B42, but not A1, inhibited T cell proliferation along with down-regulation of IL-12-induced c-Myc expression and STAT5 phosphorylation. In contrast, A1 but not B42 inhibited STAT4/STAT3 phosphorylation and IFN-gamma production. IL-18, but not IL-12, induced activator protein-1 (AP-1) responsible for high levels of IFN-gamma promoter activation. However, this IL-18 effect depended on the interaction of AP-1 with STAT4. A1 prevented AP-1 binding by inhibiting STAT4 involvement and down-regulated synergistic IFN-gamma promoter activation. These results indicate that JAK2 activation is required for IL-12-mediated T cell growth, whereas the TYK2-STAT4 signaling pathway is critical for IFN-gamma expression that is mediated by IL-12 alone and enhanced synergistically by combination with IL-18.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594853     DOI: 10.1002/immu.200390027

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Authors:  Gerard E Kaiko; Jay C Horvat; Kenneth W Beagley; Philip M Hansbro
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

2.  Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Yujin Hoshida; Shakti Ramkissoon; Lori Ramkissoon; Benjamin Rich; Cecile L Maire; Brenton R Paolella; Steven E Schumacher; Barbara Tabak; Ruben Ferrer-Luna; Memet Ozek; Aydin Sav; Sandro Santagata; Patrick Yung Wen; Liliana C Goumnerova; Azra H Ligon; Charles Stiles; Rosalind Segal; Todd Golub; Jacques Grill; Keith L Ligon; Jennifer A Chan; Mark W Kieran; Rameen Beroukhim
Journal:  Neuro Oncol       Date:  2015-03-29       Impact factor: 12.300

3.  A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis.

Authors:  Mary Anne Mashruwala; Amanda K Smith; Devin R Lindsey; Margaret Moczygemba; Rick A Wetsel; John R Klein; Jeffrey K Actor; Chinnaswamy Jagannath
Journal:  Tuberculosis (Edinb)       Date:  2011-12-05       Impact factor: 3.131

Review 4.  Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity.

Authors:  Qingxiao Song; Ubaydah Nasri; Ryotaro Nakamura; Paul J Martin; Defu Zeng
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

5.  Differential distribution of both IL-12Rbeta chains in the plasma membrane of human T cells.

Authors:  Ana Canda-Sánchez; Francisco J Salgado; Amparo Pérez-Díaz; Carla Varela-González; Pilar Arias; Montserrat Nogueira
Journal:  J Membr Biol       Date:  2008-12-09       Impact factor: 1.843

6.  Identification and characterization of rat RhoA gene promoter.

Authors:  Yoshihiko Chiba; Kumiko Goto; Kimihiko Matsusue; Shioko Kimura; Miwa Misawa
Journal:  J Pharmacol Sci       Date:  2010-03-20       Impact factor: 3.337

7.  Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells.

Authors:  Silvia Alboni; Claudia Montanari; Cristina Benatti; Manuel Sanchez-Alavez; Giovanna Rigillo; Joan M C Blom; Nicoletta Brunello; Bruno Conti; M Carmine Pariante; Fabio Tascedda
Journal:  Brain Behav Immun       Date:  2014-03-04       Impact factor: 7.217

8.  Antigen-independent IFN-γ production by human naïve CD4 T cells activated by IL-12 plus IL-18.

Authors:  Rachel B Munk; Katsuki Sugiyama; Paritosh Ghosh; Carl Y Sasaki; Louis Rezanka; Kasturi Banerjee; Hidenori Takahashi; Ranjan Sen; Dan L Longo
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

9.  Placenta-specific 8 limits IFNγ production by CD4 T cells in vitro and promotes establishment of influenza-specific CD8 T cells in vivo.

Authors:  Chris D Slade; Katie L Reagin; Hari G Lakshmanan; Kimberly D Klonowski; Wendy T Watford
Journal:  PLoS One       Date:  2020-07-08       Impact factor: 3.240

10.  Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Hengwei Wu; Jimin Shi; Yi Luo; Yamin Tan; Mingming Zhang; Xiaoyu Lai; Jian Yu; Lizhen Liu; Huarui Fu; He Huang; Yanmin Zhao
Journal:  JAMA Netw Open       Date:  2021-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.